These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 17004722)

  • 1. Multivalent effects of RGD peptides obtained by nanoparticle display.
    Montet X; Funovics M; Montet-Abou K; Weissleder R; Josephson L
    J Med Chem; 2006 Oct; 49(20):6087-93. PubMed ID: 17004722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo evaluation of a paclitaxel conjugate with the divalent peptide E-[c(RGDfK)2] that targets integrin alpha v beta 3.
    Ryppa C; Mann-Steinberg H; Biniossek ML; Satchi-Fainaro R; Kratz F
    Int J Pharm; 2009 Feb; 368(1-2):89-97. PubMed ID: 18992308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (64)Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression.
    Li ZB; Cai W; Cao Q; Chen K; Wu Z; He L; Chen X
    J Nucl Med; 2007 Jul; 48(7):1162-71. PubMed ID: 17574975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of novel dual-cyclic RGD peptides for α
    Liu J; Cheng X; Tian X; Guan D; Ao J; Wu Z; Huang W; Le Z
    Bioorg Med Chem Lett; 2019 Apr; 29(7):896-900. PubMed ID: 30732943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of Linker Molecules in Hexavalent RGD Peptides on Their Multivalent Interactions with Integrin α
    Mizuno Y; Kimura K; Onoe S; Shukuri M; Kuge Y; Akizawa H
    J Med Chem; 2021 Nov; 64(21):16008-16019. PubMed ID: 34730982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and functional evaluation of RGD-modified proteins as alpha(v)beta(3) integrin directed therapeutics.
    Kok RJ; Schraa AJ; Bos EJ; Moorlag HE; Asgeirsdóttir SA; Everts M; Meijer DK; Molema G
    Bioconjug Chem; 2002; 13(1):128-35. PubMed ID: 11792188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of integrin α
    Lv X; Zhang C; Shuaizhen Q; Yu R; Zheng Y
    Biomed Pharmacother; 2020 Aug; 128():110236. PubMed ID: 32447209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature.
    Temming K; Schiffelers RM; Molema G; Kok RJ
    Drug Resist Updat; 2005 Dec; 8(6):381-402. PubMed ID: 16309948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model.
    Janssen ML; Oyen WJ; Dijkgraaf I; Massuger LF; Frielink C; Edwards DS; Rajopadhye M; Boonstra H; Corstens FH; Boerman OC
    Cancer Res; 2002 Nov; 62(21):6146-51. PubMed ID: 12414640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bicyclic RGD Peptides with Exquisite Selectivity for the Integrin α
    Bernhagen D; Jungbluth V; Quilis NG; Dostalek J; White PB; Jalink K; Timmerman P
    ACS Comb Sci; 2019 Mar; 21(3):198-206. PubMed ID: 30624885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrin alphavbeta3 as a target for blocking HIV-1 Tat-induced endothelial cell activation in vitro and angiogenesis in vivo.
    Urbinati C; Mitola S; Tanghetti E; Kumar C; Waltenberger J; Ribatti D; Presta M; Rusnati M
    Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2315-20. PubMed ID: 16166568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing for integrin alpha v beta3 binding of RGD peptides using fluorescence polarization.
    Wang W; Wu Q; Pasuelo M; McMurray JS; Li C
    Bioconjug Chem; 2005; 16(3):729-34. PubMed ID: 15898744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic RGD-containing alpha-helical coiled coil peptides promote integrin-dependent cell adhesion.
    Villard V; Kalyuzhniy O; Riccio O; Potekhin S; Melnik TN; Kajava AV; Rüegg C; Corradin G
    J Pept Sci; 2006 Mar; 12(3):206-12. PubMed ID: 16103993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression.
    Decristoforo C; Faintuch-Linkowski B; Rey A; von Guggenberg E; Rupprich M; Hernandez-Gonzales I; Rodrigo T; Haubner R
    Nucl Med Biol; 2006 Nov; 33(8):945-52. PubMed ID: 17127166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of plasma-mediated adherence of sickle erythrocytes to microvascular endothelium by conformationally constrained RGD-containing peptides.
    Kumar A; Eckman JR; Wick TM
    Am J Hematol; 1996 Oct; 53(2):92-8. PubMed ID: 8892733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RGD-mutants of B-lymphotropic polyomavirus capsids specifically bind to alpha(v)beta3 integrin.
    Langner J; Neumann B; Goodman SL; Pawlita M
    Arch Virol; 2004 Oct; 149(10):1877-96. PubMed ID: 15290355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide-mediated gene transfer of cationic lipid/plasmid DNA complexes to endothelial cells.
    Anwer K; Kao G; Rolland A; Driessen WH; Sullivan SM
    J Drug Target; 2004 May; 12(4):215-21. PubMed ID: 15506170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RGD-dependent binding of procathepsin X to integrin alphavbeta3 mediates cell-adhesive properties.
    Lechner AM; Assfalg-Machleidt I; Zahler S; Stoeckelhuber M; Machleidt W; Jochum M; Nägler DK
    J Biol Chem; 2006 Dec; 281(51):39588-97. PubMed ID: 17065156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. alpha(v)beta(3) Integrin-targeting radionuclide therapy and imaging with monomeric RGD peptide.
    Yoshimoto M; Ogawa K; Washiyama K; Shikano N; Mori H; Amano R; Kawai K
    Int J Cancer; 2008 Aug; 123(3):709-15. PubMed ID: 18498129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.